Koyfin alternatives
Koyfin alternatives
for investors who screen
more than they chart.
Koyfin Plus is $39/month and built around dashboards and charting. If most of your time is in the screener — not the charts — you are paying for features you rarely use. These alternatives are built screening-first and cover European markets more deeply.
Updated October 2026 · 5 alternatives reviewed
What a screening-first tool gives you over Koyfin
No charting tax
Koyfin is designed around charts and dashboards. ScreenerHero is designed around the screener. You pay for what you use — not for charting infrastructure you open twice a month.
European microcap depth
Koyfin covers large and mid caps globally. European microcaps and illiquid names have coverage gaps. ScreenerHero includes all European exchanges — microcaps first-class.
No monthly fee
Koyfin Plus is $39/month. The ScreenerHero paid plan is a one-time Lifetime payment, for a tool that is screening-first rather than charting-first.
Free core screener
ScreenerHero's core screener is free with no account required. Test the coverage and filter depth before committing to Pro.
What to look for in a Koyfin alternative
Screener as the primary product
Is screening the core of the tool, or a secondary feature added to a charting or dashboard platform?
European microcap fundamental data
P/E, ROE, EV/EBITDA for European small and microcap names — are they populated, or is the EU coverage limited to large caps?
Price relative to workflow
If you rarely use charts, you should not be paying $39/month for charting infrastructure. Match the cost to your actual workflow.
Filter depth
Can you combine 40+ fundamental filters freely across all markets, or does the plan gate certain columns?
Dense output
Results should be a dense, sortable table you can scan in seconds — not dashboards, not cards.
The 5 best Koyfin alternatives for screening (2026)
ScreenerHero
Screening-first. US + Canada + Europe + Australia. No subscription.
ScreenerHero is screening-first — the screener is the product, not a feature tab. Filter by fundamentals across US, Canadian, Australian, and all European equities including microcaps. Paid access is a one-time Lifetime payment, where Koyfin Plus is $39/month, with better European microcap coverage and no charting tax. Free core screener with no account required.
Markets
US, Canada, Australia, BME, Euronext Paris, XETRA, Borsa Italiana — all European exchanges
Screener filters
P/E, P/B, ROE, EV/EBITDA, margins, beta, momentum, dividend yield
UI style
Desktop-first, data-dense, built around the screener
Heatmap
Yes
Finviz
The benchmark for dense US screening — no meaningful European coverage
The reference standard for dense, fast screener UX. Finviz Elite is $39.50/month — more than Koyfin Plus and more than ScreenerHero — but covers US equities only. If you screen US names and want maximum density, Finviz is the benchmark. For European coverage, look elsewhere.
Markets
US primarily
Screener filters
P/E, P/B, ROE, margins, momentum — US equities only
UI style
Desktop-first, data-dense, screener-first
Heatmap
Yes
Stockopedia
Score-driven research for European equities — expensive, no US
StockRanks is a respected quality/value/momentum composite, useful for UK equities. No Canadian equities. Continental European microcap coverage has gaps. At €60–80/month it is a recurring subscription for narrower coverage than ScreenerHero.
Markets
UK-weighted, some continental Europe (no Canada)
Screener filters
StockRanks composite (QVM) + custom filters
UI style
Card-based, research-oriented
Heatmap
No
TIKR
Broad global coverage, loyal user base — EU microcap depth is limited
TIKR Plus is priced aggressively at $25/month with broad global coverage. European microcap and illiquid stock coverage is a known gap. TIKR Pro runs $40–55/month — more expensive than Koyfin Plus for a less polished experience.
Markets
100k+ stocks, 92 countries
Screener filters
Fundamentals, historical financials, transcripts on Pro
UI style
Data-focused, less dense UI
Heatmap
No
MarketScreener
Deep European data, news-first, screener is secondary
Broadest European fundamental database available. The product is built around analyst consensus and news — screening is secondary and the interface is dated. Cheaper than Koyfin Plus but not a screener-first alternative.
Markets
Europe and global
Screener filters
300–600 filters including analyst estimates
UI style
Table-based, slow, built around analyst reports
Heatmap
No
Quick comparison
| ScreenerHero | Finviz | Stockopedia | TIKR | MarketScreener | |
|---|---|---|---|---|---|
| US coverage | |||||
| Canadian coverage | |||||
| European coverage | |||||
| Microcap EU coverage | |||||
| Screener-first UX | |||||
| Dense table UI | |||||
| Heatmap | |||||
| Free core features | |||||
| No account required | |||||
| Paid plan (from) | 97€ once | $39.50/mo | €60/mo | $10/mo | $30/mo |
Recommendation by use case
You screen more than you chart, across US, Canadian, European & Australian markets
ScreenerHero — screening-first, full EU microcap depth, free core screener, one-time paid plan.
You use charts and screening in equal measure
Koyfin — the charting is genuinely excellent; accept the $39/month and the screener as secondary.
You screen US stocks only and want maximum UI density
Finviz — the benchmark for dense US screening, at $39.50/month.
You prefer composite QVM scores over raw filter sliders
Stockopedia — well-regarded for UK equities, accept the €60–80/month and coverage limits.
You want the broadest global coverage at the lowest price
TIKR Plus — $25/month, wide reach, accept European microcap gaps.
Koyfin vs ScreenerHero for a screening workflow
If your Koyfin routine is: open the screener, set fundamental filters (P/E, ROE, margin, growth), get a list of candidates, open a few stock pages and then research elsewhere, Koyfin's distinctive features (macro dashboards, long statement history, custom formulas) are not part of it. You are paying for a screener that lives inside a platform built for broader uses.
Koyfin's screener strengths: hundreds of screening metrics, percentile-rank filters (for example the top decile of a metric globally), and integration with the rest of Koyfin's research workflow if you use it.
ScreenerHero's strengths: European small-cap and microcap coverage that Koyfin lacks, a free core screener without an account, a market heatmap by sector and country, and a one-time payment instead of a monthly fee.
The decision is not which screener has more filters. It is whether Koyfin's extra filters serve your actual process, and whether its gaps in smaller European companies affect the markets you care about.
When Koyfin is still the right choice
If macro overlays are part of your process. Koyfin’s dashboards of GDP growth, central bank rates, yield curves and credit spreads help top-down investors who start from a macro view before picking stocks. No screener-first alternative replicates them.
If you want long financial statement history in the same platform, for example to build multi-year DCF models without switching tools.
If percentile-rank filters matter to you. Screening for the top 20% of companies by ROIC is a different kind of filter from a raw threshold; for factor-based, percentile-driven strategies Koyfin’s approach is genuinely different.
Frequently asked questions
Is there a free Koyfin alternative?
For financial statement data, Stock Analysis (stockanalysis.com) is the closest free alternative. For screening, ScreenerHero's core screener is free without an account and covers US, Canadian, European and Australian stocks.
What is Koyfin best for?
Koyfin is best for investors who want one platform for screening, macro data, historical statements and portfolio tracking: a research terminal rather than a screener. Investors who mainly screen and do not use the macro or historical features pay for capabilities they do not need.
Does Koyfin cover European stocks well?
Koyfin covers European large and mid caps adequately. For small caps and microcaps, particularly on Euronext Growth, Nasdaq First North, Euronext Growth Milan and NewConnect, filter results can come back empty or stale. Investors focused on smaller European companies get better data from a screener built around the European exchanges.
How does ScreenerHero pricing compare with Koyfin?
Koyfin Plus: $39 a month; annual billing is up to 30% cheaper (checked 13 Oct 2026). ScreenerHero's core screener is free, and its paid plan is a single Lifetime payment with no monthly fee.
Which has better European coverage: Koyfin or ScreenerHero?
ScreenerHero has broader and more reliable European coverage, especially for small caps and growth-market names. Koyfin covers European large and mid caps well but has gaps in the smaller companies that European investors often care about most.
Less than Koyfin. Built for screening.
Dense tables. Fast filters. Heatmap. US, Canadian, European & Australian equities — including microcaps — in one screening-first tool. Free, no account needed. Lifetime access is a one-time 97€ payment — no subscription.